Skip to Main Content

Paper Details

Immunomodulatory treatment of immune checkpoint inhibitor-induced myocarditis: Pathway toward precision-based therapy.
Cardiovascular Pathology
27
2020
Cancer, ICI-myocarditis, IVIG, T cells, acute cellular rejection, advanced malignancy, anti, autoimmune disorders, cancer, colchicine, heart failure, hydroxychloroquine, immunoglobulins, lymphocytic myocarditis, myocarditis, patient, patients, statins
Author NameAffiliation
Dennis M McNamaraUniversity of Pittsburgh Medical Center Heart and Vascular Institute
  • 1 - 1

Datasets

Release 1.2